logo-loader
viewPolar Capital Global Healthcare Trust PLC

Polar Capital Global Healthcare adds stake in AstraZeneca, ups Pfizer holding

A notable exit from the groups top 10 was Johnson & Johnson, which in the last update for the end of April had taken up 8.6% of the portfolio

Polar Capital Global Healthcare Trust PLC - Polar Capital Global Healthcare adds stake in AstraZeneca, ups Pfizer holding

Polar Capital Global Healthcare Trust PLC (LON:PCGH) had added a stake in UK pharma giant AstraZeneca PLC (LON:AZN) to its top ten holdings, while also increasing its share of US group Pfizer Inc (NYSE:PFE).

In a portfolio update as of 31 May, the investment manager revealed a stake in AZ accounting for 3.7% of its holdings, while its Pfizer holding has increased its share to 5.6% from 4.6% in April.

A notable exit from the groups top 10 was Johnson & Johnson (NYSE:JNJ), which in the last update for the end of April had taken up 8.6% of the portfolio.

In terms of sectors, healthcare equipment was the largest segment in the portfolio at 38%, up from 33.1% the previous month, while the previous largest sector, pharmaceuticals, has been reduced to 30.6% from 36.4%.

Meanwhile, the US continued to top the list for the firm’s geographic exposure at 65.5% of the total portfolio, up slightly month-on-month from 65.1%, while the group had increased its exposure to the UK to 14.9% from 11.5%. The firm also added a 0.3% exposure to the French market.

Quick facts: Polar Capital Global Healthcare Trust PLC

Price: 250 GBX

LSE:PCGH
Market: LSE
Market Cap: £303.18 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Polar Capital Global Healthcare Trust PLC named herein, including the promotion by the Company of Polar Capital Global Healthcare Trust PLC in...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian Strategic Materials produces first titanium metal alloy with JV...

Australian Strategic Materials Limited’s David Woodall speaks to Proactive's Andrew Scott after announcing its JV partner ZironTech has successfully produced a titanium metal alloy at their commercial pilot plant in South Korea. He says it achieved 99.9% purity and importantly it uses about 45%...

1 day, 7 hours ago